European HTA Review
€29,000.00
HTA decision review in France, Germany and the UK (may also include proxy diseases, if applicable; only decisions that are openly communicated in English/GER language included) covering 2-3 decisions per country.
Timeline: 4 weeks
HTA decision review in France, Germany and the UK (may also include proxy diseases, if applicable; only decisions that are openly communicated in English/GER language included) covering 2-3 decisions per country.
Timeline: 4 weeks
HTA decision review in France, Germany and the UK (may also include proxy diseases, if applicable; only decisions that are openly communicated in English/GER language included) covering 2-3 decisions per country.
Timeline: 4 weeks